ZNF573
Zinc finger protein 573
Also known as: FLJ30921, ZN573_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86YE8
- Gene
- ZNF573
- Ensembl
- ENSG00000189144
- Chromosome
- 19
- Canonical length
- 665 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Intermediate filaments,Cytosol
OverviewNCBI Gene
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
665 residues, UniProt reviewed canonical sequence.
>Q86YE8|ZNF573
1 MFPVLEPHQV GLIRSYNSKT MTCFQELVTF RDVAIDFSRQ EWEYLDPNQR DLYRDVMLEN
61 YRNLVSLGGH SISKPVVVDL LERGKEPWMI LREETQFTDL DLQCEIISYI EVPTYETDIS
121 STQLQSIYKR EKLYECKKCQ KKFSSGYQLI LHHRFHVIER PYECKECGKN FRSGYQLTLH
181 QRFHTGEKPY ECTECGKNFR SGYQLTVHQR FHTGEKTYEC RQCGKAFIYA SHIVQHERIH
241 TGGKPYECQE CGRAFSQGGH LRIHQRVHTG EKPYKCKECG KTFSRRSNLV EHGQFHTDEK
301 PYICEKCGKA FRRGHQLTVH QRVHTGKKPY ECKECGKGYT TASYFLLHQR IHKGGKPYEC
361 KECKKTFTLY RNLTRHQNIH TGEKLFECKQ CGKTYTTGSK LFQHQKTHTG EKPYECKECG
421 KAFSLYGYLK QHQKIHTGMK HFECKECKKT FTLYRNLTRH QNIHTGKKLF ECQECGKAYS
481 TGSNLIQHRK THTGEKPYKC KECGKTFSLH GYLNQHQKIH TGMKPYECKV CRKTFTFYRN
541 LTLHQSIHTD EKPFECKECG KTFRRSSHLT AHQSIHADKK PYECKECGKA FKMYGYLTQH
601 QKIHTGGKPY ECKECGKAFS RASNLVQHER IHTGEKPYVC KQCGKTFRYG SALKAHQRIH
661 RSIKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF573 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 2.7 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 2.7 nTPM
- retina: 2.3 nTPM
- thyroid gland: 2.3 nTPM
- skin: 2 nTPM
- stomach: 1.9 nTPM
- bone marrow: 1.8 nTPM
Single-cell type
- late spermatids: 452 nCPM
- early spermatids: 221 nCPM
- somatotrophs: 108 nCPM
- lactotrophs: 78 nCPM
- late primary spermatocytes: 75 nCPM
- adrenal medulla cells: 75 nCPM
Immune cell
- naive B-cell: 2.8 nTPM
- naive CD4 T-cell: 2.6 nTPM
- basophil: 2.1 nTPM
- memory CD8 T-cell: 2.1 nTPM
- gdT-cell: 2 nTPM
- naive CD8 T-cell: 2 nTPM
Brain region
- cerebellum: 15 nTPM
- hypothalamus: 11 nTPM
- white matter: 10 nTPM
- cerebral cortex: 8.6 nTPM
- basal ganglia: 8.4 nTPM
- thalamus: 7.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF573 as an antibody target. Whether an autoantibody or antibody against ZNF573 could matter depends on whether native ZNF573 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF573 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF573 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...